ArticleJournal of the American Chemical Society2026
Self-Disproportionation-Induced H-Adsorption/Desorption Zones in Amorphous Nickel Boride Cocatalyst for Efficient Photocatalytic Hydrogen Evolution.
Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydrogen spillover is a well-established strategy for enhancing hydrogen evolution kinetics; however, in conventional binary-component catalysts, its efficiency is often limited by long diffusion distances and significant interfacial resistance. Herein, we developed an efficient intraparticle hydrogen spillover pathway in isolated amorphous nickel boride (a-NiB) cocatalysts through an amorphization-induced self-disproportionation strategy, which significantly enhances H
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.